Clopidogrel and CYP2C19 testing: Ready for clinical prime time?

Jean Sébastien Hulot, Roger Hajjar, Gilles Montalescot

Research output: Contribution to journal › Comment/debate

7 Scopus citations

Access to Document

@article{c84bfa5769c847a4af55fda712930a5c,

title = "Clopidogrel and CYP2C19 testing: Ready for clinical prime time?",

author = "Hulot, {Jean S{\'e}bastien} and Roger Hajjar and Gilles Montalescot",

year = "2012",

month = jan,

doi = "10.1373/clinchem.2011.165829",

language = "English",

volume = "58",

pages = "154--157",

journal = "Clinical Chemistry",

issn = "0009-9147",

publisher = "Oxford University Press",

number = "1",

}

TY - JOUR

T1 - Clopidogrel and CYP2C19 testing

T2 - Ready for clinical prime time?

AU - Hulot, Jean Sébastien

AU - Hajjar, Roger

AU - Montalescot, Gilles

PY - 2012/1

Y1 - 2012/1

UR - http://www.scopus.com/inward/record.url?scp=84856071768&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2011.165829

DO - 10.1373/clinchem.2011.165829

M3 - Comment/debate

C2 - 21940658

AN - SCOPUS:84856071768

SN - 0009-9147

VL - 58

SP - 154

EP - 157

JO - Clinical Chemistry

JF - Clinical Chemistry

IS - 1

ER -